Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene

doi:10.1084/jem.179.3.797

This Article

	Full Text (PDF, 1219K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Lindemann, D.
	Articles by Mous, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Lindemann, D.
	Articles by Mous, J.


Social Bookmarking

	What's this?

ARTICLES

Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene

D Lindemann, R Wilhelm, P Renard, A Althage, R Zinkernagel and J Mous
Department of Biology, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

We have generated several transgenic mouse strains carrying a human immunodeficiency virus 1 (HIV-1) NEF/3' long terminal repeat (LTR) transgene under control of a T cell-specific promoter-enhancer element, showing a depletion of CD4+ T cells in the thymus and periphery. The immunological functions of the line with the most dramatic changes in lymphocyte populations, B6/338L, were analyzed in greater detail. The presence of the transgene in the heterozygous animal is associated with a dominant severe immunodeficiency. Older animals develop lymph- adenopathy and splenomegaly. CD4+CD8+ and CD4+CD8- single positive thymocytes already are depleted in these mice at the earliest stages in ontogeny, and peripheral T cells are reduced in frequency and present cell surface marker expression, which is characteristic for memory and activated T cells. The immunological response of B6/338L mice to several viral infections is also greatly impaired. Thus, the HIV-1 NEF/3' LTR as transgene in T cells can cause immunodeficiency and disease with striking similarities to a known retrovirus-induced immunodeficiency called murine AIDS (H. C. Morse III, S. K. Chattopadhyay, M. Makino, T. N. Frederickson, A. W. Hugin, and J. W. Hartley. 1992. AIDS. 6:607).
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Priceputu, E., Hanna, Z., Hu, C., Simard, M.-C., Vincent, P., Wildum, S., Schindler, M., Kirchhoff, F., Jolicoeur, P. (2007). Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice. J. Virol. 81: 4677-4693 [Abstract] [Full Text]
Koenen, P. G. F., Hofhuis, F. M., Oosterwegel, M. A., Tesselaar, K. (2007). T Cell Activation and Proliferation Characteristic for HIV-Nef Transgenic Mice Is Lymphopenia Induced. J. Immunol. 178: 5762-5768 [Abstract] [Full Text]
de Repentigny, L., Lewandowski, D., Jolicoeur, P. (2004). Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection. Clin. Microbiol. Rev. 17: 729-759 [Abstract] [Full Text]
Weng, X., Priceputu, E., Chrobak, P., Poudrier, J., Kay, D. G., Hanna, Z., Mak, T. W., Jolicoeur, P. (2004). CD4+ T Cells from CD4C/HIVNef Transgenic Mice Show Enhanced Activation In Vivo with Impaired Proliferation In Vitro but Are Dispensable for the Development of a Severe AIDS-Like Organ Disease. J. Virol. 78: 5244-5257 [Abstract] [Full Text]
Rauer, M., Gotz, J., Schuppli, D., Staeheli, P., Hausmann, J. (2004). Transgenic Mice Expressing the Nucleoprotein of Borna Disease Virus in either Neurons or Astrocytes: Decreased Susceptibility to Homotypic Infection and Disease. J. Virol. 78: 3621-3632 [Abstract] [Full Text]
Stove, V., Naessens, E., Stove, C., Swigut, T., Plum, J., Verhasselt, B. (2003). Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development. Blood 102: 2925-2932 [Abstract] [Full Text]
Nelson, P. J., D'Agati, V. D., Gries, J.-M., Suarez, J.-R., Gelman, I. H. (2003). Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J Antimicrob Chemother 51: 921-929 [Abstract] [Full Text]
Stoddart, C. A., Geleziunas, R., Ferrell, S., Linquist-Stepps, V., Moreno, M. E., Bare, C., Xu, W., Yonemoto, W., Bresnahan, P. A., McCune, J. M., Greene, W. C. (2003). Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis. J. Virol. 77: 2124-2133 [Abstract] [Full Text]
Simard, M.-C., Chrobak, P., Kay, D. G., Hanna, Z., Jothy, S., Jolicoeur, P. (2002). Expression of Simian Immunodeficiency Virus nef in Immune Cells of Transgenic Mice Leads to a Severe AIDS-Like Disease. J. Virol. 76: 3981-3995 [Abstract] [Full Text]
Hanna, Z., Weng, X., Kay, D. G., Poudrier, J., Lowell, C., Jolicoeur, P. (2001). The Pathogenicity of Human Immunodeficiency Virus (HIV) Type 1 Nef in CD4C/HIV Transgenic Mice Is Abolished by Mutation of Its SH3-Binding Domain, and Disease Development Is Delayed in the Absence of Hck. J. Virol. 75: 9378-9392 [Abstract] [Full Text]
Arora, V. K., Molina, R. P., Foster, J. L., Blakemore, J. L., Chernoff, J., Fredericksen, B. L., Garcia, J. V. (2000). Lentivirus Nef Specifically Activates Pak2. J. Virol. 74: 11081-11087 [Abstract] [Full Text]
Verhasselt, B., Naessens, E., Verhofstede, C., De Smedt, M., Schollen, S., Kerre, T., Vanhecke, D., Plum, J. (1999). Human Immunodeficiency Virus nef Gene Expression Affects Generation and Function of Human T Cells, But Not Dendritic Cells. Blood 94: 2809-2818 [Abstract] [Full Text]
Greenway, A. L., Dutartre, H., Allen, K., McPhee, D. A., Olive, D., Collette, Y. (1999). Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1�Nef Proteins Show Distinct Patterns and Mechanisms of Src Kinase Activation. J. Virol. 73: 6152-6158 [Abstract] [Full Text]
Mangasarian, A., Piguet, V., Wang, J.-K., Chen, Y.-L., Trono, D. (1999). Nef-Induced CD4 and Major Histocompatibility Complex Class I (MHC-I) Down-Regulation Are Governed by Distinct Determinants: N-Terminal Alpha Helix and Proline Repeat of Nef Selectively Regulate MHC-I Trafficking. J. Virol. 73: 1964-1973 [Abstract] [Full Text]
Zauli, G., Gibellini, D., Secchiero, P., Dutartre, H., Olive, D., Capitani, S., Collette, Y. (1999). Human Immunodeficiency Virus Type 1�Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway. Blood 93: 1000-1010 [Abstract] [Full Text]
SKOWRONSKI, J., GREENBERG, M.E., LOCK, M., MARIANI, R., SALGHETTI, S., SWIGUT, T., IAFRATE, A.J. (1999). HIV and SIV Nef Modulate Signal Transduction and Protein Sorting in T Cells. Cold Spring Harb Symp Quant Biol 64: 453-464 [Abstract]
Hanna, Z., Kay, D. G., Cool, M., Jothy, S., Rebai, N., Jolicoeur, P. (1998). Transgenic Mice Expressing Human Immunodeficiency Virus Type 1�in Immune Cells Develop a Severe AIDS-Like Disease. J. Virol. 72: 121-132 [Abstract] [Full Text]
Collette, Y., Dutartre, H., Benziane, A., Ramos-Morales, F., Benarous, R., Harris, M., Olive, D. (1996). Physical and Functional Interaction of Nef with Lck. J. Biol. Chem. 271: 6333-6341 [Abstract] [Full Text]